A drug with the SMILES Cc1oc2cc3oc(=O)c(CC(=O)N[C@H](C(=O)N[C@@H](C(=O)O)c4ccccc4)C(C)C)c(C)c3cc2c1C has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 1.616\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
Cc1oc2cc3oc(=O)c(CC(=O)N[C@H](C(=O)N[C@@H](C(=O)O)c4ccccc4)C(C)C)c(C)c3cc2c1C
Cc1oc2cc3oc(=O)c(CC(=O)N[C@H](C(=O)N[C@@H](C(=O)O)c4ccccc4)C(C)C)c(C)c3cc2c1C
(2R)-2-[[(2S)-3-methyl-2-[[2-(2,3,5-trimethyl-7-oxofuro[3,2-g]chromen-6-yl)acetyl]amino]butanoyl]amino]-2-phenylacetic acid